WASHINGTON — For the first time, federal health officials are taking aim at telehealth companies promoting unofficial versions of prescription drugs — including popular weight loss medications — as ...
Sept 16 (Reuters) - The U.S. Food and Drug Administration issued warning letters to Eli Lilly (LLY.N), opens new tab, Novo Nordisk (NOVOb.CO), opens new tab and telehealth firm Hims & Hers Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback